Shinpoong Pharmaceutical Co (XKRX:019170) Beta: 0.3864 (As of Sep. 15, 2026)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

XKRX:019170 Shinpoong Pharmaceutical Co Ltd XKRX:019170
65 GF Score
Price ₩10,070.00
GF Value ₩11,210.54
Valuation Modestly Undervalued
! 1 Warning Sign
View Full Analysis

What is Shinpoong Pharmaceutical Co Beta?

Shinpoong Pharmaceutical Co XKRX:019170 +0.50% 65 Beta is 0.3864 as of Sep. 15, 2026. GuruFocus rates XKRX:019170 with a GF Score™ of 65/100 and a GF Value™ of ₩11,210.54 (Modestly Undervalued). The stock has 1 warning sign investors should review.

Beta is the sensitivity of the expected excess asset returns to the expected excess market returns. As of today (2026-09-15), Shinpoong Pharmaceutical Co's Beta is 0.3864.


Shinpoong Pharmaceutical Co  (XKRX:019170) Beta Explanation

Beta is a measure of the volatility, or systematic risk, of a security or a portfolio in comparison to the market as a whole. We usually compare beta to 1. A beta of 1 indicates that the security's price will move with the market. A beta of less than 1 means that the security will be less volatile than the market. A beta of greater than 1 indicates that the security's price will be more volatile than the market.

Beta is primarily used in the Capital Asset Pricing Model (CAPM) to calculate the Cost of Equity, which can be used in the calculation of WACC %. The formula of Cost of Equity is:
Cost of Equity = Risk-Free Rate of Return + Beta of Asset * (Expected Return of the Market - Risk-Free Rate of Return)


Shinpoong Pharmaceutical Co Beta Related Terms


Shinpoong Pharmaceutical Co Beta Historical Data

* Premium members only.

The historical data trend for Shinpoong Pharmaceutical Co's Beta can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Shinpoong Pharmaceutical Co Beta Chart

Shinpoong Pharmaceutical Co Annual Data
Trend Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
Beta
Get a 7-Day Free Trial Premium Member Only Premium Member Only 0.90 1.34 1.73 -0.54 0.62

Shinpoong Pharmaceutical Co Quarterly Data
Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26 Jun26
Beta Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 1.77 1.44 0.62 0.59 0.38

XKRX:019170 vs ZTS: Beta Comparison

For the Drug Manufacturers - Specialty & Generic subindustry, Shinpoong Pharmaceutical Co's Beta, along with its competitors' market caps and Beta data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Shinpoong Pharmaceutical Co Beta vs Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Shinpoong Pharmaceutical Co's Beta distribution charts can be found below:

* The bar in red indicates where Shinpoong Pharmaceutical Co's Beta falls into.


XKRX:019170
65GF Score
Shinpoong Pharmaceutical Co Ltd XKRX:019170
Beta is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Shinpoong Pharmaceutical Co Beta Calculation

Beta is the sensitivity of the expected excess asset returns to the expected excess market returns. A stock's beta can be calculated by dividing the product of the covariance of the individual stock's returns and the market's returns by the variance of the market's returns over a specified period. Basically, GuruFocus uses the returns calculated over three-year period.

Frequently Asked Questions Learn more about Beta →
What does a Beta of 0.3864 mean?
Shinpoong Pharmaceutical Co (XKRX:019170) has a Beta of 0.3864 as of Sep. 15, 2026. Beta is the sensitivity of the expected excess asset returns to the expected excess market returns. View historical data for Shinpoong Pharmaceutical Co and its competitors.
Is Shinpoong Pharmaceutical Co's Beta too high?
Shinpoong Pharmaceutical Co's current Beta is 0.3864. Overall, Shinpoong Pharmaceutical Co has a GF Score™ of 65/100 and is considered Modestly Undervalued, reflecting its overall financial health beyond just this single metric.
How does Shinpoong Pharmaceutical Co's Beta compare to ZTS?
Shinpoong Pharmaceutical Co's Beta of 0.3864 can be compared against companies in the Drug Manufacturers industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Beta for a Drug Manufacturers company?
A good Beta depends on the Drug Manufacturers industry context. However, Beta should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Beta mean?
A high Beta can signal that a stock is expensive relative to its fundamentals. Beta is the sensitivity of the expected excess asset returns to the expected excess market returns. View historical data for Shinpoong Pharmaceutical Co and its competitors. Shinpoong Pharmaceutical Co's current Beta is 0.3864. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Shinpoong Pharmaceutical Co stock overvalued right now?
Based on GuruFocus' analysis, Shinpoong Pharmaceutical Co (XKRX:019170) is currently considered Modestly Undervalued. The stock's GF Value™ is ₩11,210.54, compared to a current price of ₩10,070.00 — trading 10.2% below its estimated fair value. The current Beta is 0.3864. Shinpoong Pharmaceutical Co's overall GF Score™ is 65/100 with 1 warning sign to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Beta calculated?
Beta is calculated from a company's financial statements. For Shinpoong Pharmaceutical Co (XKRX:019170), the current Beta is 0.3864 as of Sep. 15, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Shinpoong Pharmaceutical Co (XKRX:019170) Overvalued in 2026?

Based on GuruFocus' analysis, Shinpoong Pharmaceutical Co stock appears to be undervalued. The current stock price of ₩10,070.00 is trading 10.2% below its estimated GF Value™ of ₩11,210.54. GuruFocus considers Shinpoong Pharmaceutical Co to be Modestly Undervalued.

Key valuation signals for XKRX:019170:

  • Beta: 0.3864
  • GF Value™: ₩11,210.54 vs. price of ₩10,070.00 (10.2% below fair value)
  • GF Score™: 65/100 with 1 warning sign

No single metric tells the full story. See the XKRX:019170 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.


Shinpoong Pharmaceutical Co Business Description

Other Exchanges 019175:Korea
Address 161, Yeoksam-ro, Gangnam-gu, Seoul, KOR, 06246
Shinpoong Pharmaceutical Co Ltd specializes in manufacturing remedy drugs and also active pharmaceutical ingredients and finished products. Its products include Newsicam, Caravenal, Roxagen, Clamoxin duo, Ceroxim, and Clocin. The firm's production facilities are located at Gyeonggi-do and Cheongwon-gun.
65GF Score

Get the complete analysis for XKRX:019170

Beta is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

₩10,070.00
Price
₩11,210.54
GF Value